European Archives - Page 590 of 1056 - European Medical Journal

Continue
3 Mins
21 Jul 2020

EULAR COVID-19 Recommendations

TREATING patients with autoimmune diseases, the rheumatology community is naturally concerned with the spread of COVID-19; as Prof Robert Landewé…
4 Mins
21 Jul 2020

EULAR 2020 Interview: Dr Rikke Helene Moe

It was evident from the start; I knew I had to work in this field already when I was a student. The people with rheumatic diseases whom I met taught me…
1 Mins
21 Jul 2020

Predicting Rheumatoid Arthritis Using the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire

Accurate prediction of rheumatoid arthritis (RA) development in persons at risk of RA can help to select individuals for early intervention trials…
6 Mins
21 Jul 2020

Latest Highlights on Biologic Treatments for Psoriatic Arthritis from EULAR 2020

Psoriatic arthritis (PsA) is a chronic, heterogeneous, immune-mediated arthritis characterised by joint inflammation and diverse clinical manifestations…
2 Mins
21 Jul 2020

Are Coping Strategies, Anxiety, and Depression Associated with Daily Physical Activity in Patients With Axial Spondyloarthritis?

Patients with axial spondyloarthritis (axSpA) who are more physically active experience less pain and better physical functioning…
6 Mins
21 Jul 2020

EULAR 2020 Interview: Ms Sue Oliver OBE

When I started my masters, I think that I was always keen to have a role where I could make a bit of a difference and so finding a way to do that felt right…
3 Mins
21 Jul 2020

Interview: Clinical Prof Daniel Wallace

Clinical Prof Daniel Wallace   |  Rheumatologist, Cedars-Sinai Medical Center and Ronald Reagan UCLA Medical Center, Los Angeles,  California, USA…
6 Mins
21 Jul 2020

Early Recognition and Treatment of Spondyloarthritis: A Timeless Challenge

Spondyloarthritis (SpA) is a chronic systemic rheumatic disease, the hallmark manifestation of which is inflammatory back pain, and may also involve…
2 Mins
21 Jul 2020

Improving Risk-Stratification of Patients with Rheumatoid Arthritis for Interstitial Lung Disease

Interstitial lung disease (ILD) is a common pulmonary manifestation of rheumatoid arthritis (RA). It has emerged in recent studies as a key prognostic…
2 Mins
21 Jul 2020

2019 Update of the Joint European League Against Rheumatism (EULAR) and European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) Recommendations for the Management of Lupus Nephritis

A significant proportion of patients with systemic lupus erythematosus develop renal disease, which has a major impact on the course of the disease…